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LCAM-1 and VCAM-1 in human renal allograft rejection. Light micros-
copy studies have demonstrated heightened ICAM-1 and VCAM-1 ex-
pression in renal allograft rejection in experimental animals and in
humans, and administration of ICAM-1 blocking antibodies has been
shown to prolong graft survival in nonhuman primates. We used a precise
ultrastructural immunogold localization technique to identify the exact
sites of expression of ICAM-1 and VCAM-1 in both normal human kidney
and in renal allograft rejection. In the normal kidney ICAM-1 is moder-
ately strongly expressed in glomeruli, on the endothelium and parietal
epithelium and in the intcrstitium, on the endothelium of peritubular
capillaries, arterioles and small arteries, on fibroblast-like interstitial cells
and on the brush border of proximal tubules. In contrast, in normal
kidney, VCAM-1 expression is restricted to the parietal epithelium and
the basolateral surfaces of a few proximal tubule cells. In allograft
rejection, although ICAM-1 expression appears to he increased, its
pattern of distribution is similar to that seen in the normal kidney.
However, VCAM-1 in allograft rejection is widely expressed on the
endothelium of peritubular capillaries and arterioles in association with
adhesion of mononuclear leukocytes within these vessels. The tubular
expression of VCAM-1, although still focal in nature, is increased on the
basolateral surfaces in association with lymphocytic infiltration of tubules.
Although ICAM-1 expression appears to be up-regulated in renal allograft
rejection in a pattern of distribution similar to that seen in the normal
kidney, we postulate that it is VCAM-1 which appears on the perituhular
capillary endothclium and is strongly focally expressed on the basolateral
surfaces of tubules, which is perhaps more strategically placed to be the
most relevant adhesion molecule in allograft rejection.
Renal transplant rejection is characterized by vascular and
tubulointerstitial components with a mononuclear cell infiltrate
composed of predominantly lymphocytes and monocytes [1].
Morphologic studies have demonstrated heightened ICAM-1 and
VCAM-1 expression on vascular and tubulointerstitial cells in
renal allograft rejection in both human [2—9] and experimental
studies [10—12]. Renkonen et al [13], using an & vivo binding
assay, demonstrated that lymphocytes enter the rejecting kidney
via the peritubular capillary endothelium, and that this could be
partly blocked by pretreatment of the lymphocytes with LFA-1
antibodies but not by pretreatment of the tissues with ICAM-1
antibodies. ICAM-1 antibodies have been tested in the treatment
of renal allograft rejection in monkeys and were found to decrease
T cell infiltration in the graft and to significantly prolong survival
[10]. Antibodies to VCAM-1 have been shown to prolong cardiac
allograft survival [14] in mice, but have not been tested in renal
allograft rejection.
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To further understand the role of the leukocyte adhesion
molecules ICAM-1 and VCAM-1 in renal allograft rejection, we
have used ultrastructural analysis to define their precise localiza-
tion first in the normal human kidney, and then compared this
with renal allograft rejection.
Methods
Two biopsies from unused renal transplants, considered as
normal human kidney, and four biopsies from chronic renal
transplant rejection (at 6 months post-transplant) were studied.
Monoclonal antibodies
Mouse monoclonal antibodies(mAb) used in this study were as
follows: HU513(IgGl), mAb to human ICAM-1 [15] and E1/6
(IgGi), mAb to human VCAM-1 [16]. Both mAb were in
supernatant form.
Immunohistochemistiy
Kidney for immunoperoxidase staining was immersion fixed in
periodate-lysine-paraformaldehyde (PLP) for two hours. Serial 6
r cryostat sections were cut and stained as previously described
[17]. The mouse monoclonal antibodies, diluted 1 in 4, were
visualized with a three-layer immunoperoxidase technique using
peroxidase conjugated goat anti-mouse IgG and mouse peroxi-
dase anti-peroxidase complexes followed by development with
3 '3' -diaminobenzidine(DAB, Sigma) and counterstaining with
Harris' hemotoxylin.
Immunoelectronmicroscopy
Renal biopsy specimens were immersion fixed in PLP for two
hours. The tissue was then immersed in increasing concentrations
of sucrose (5% up to 20%) in 0.1 M phosphate buffered saline
(PBS) pH 7.4 over 36 hours, and then placed in OCT and snap
frozen in liquid nitrogen. Subsequently 30 tim cryostat sections
were cut and incubated in 5% normal goat serum (NGS) in 0.01
M PBS, 0.8% bovine serum albumin (BSA) and 0.1% LGGS
quality gelatin as a blocking step, and then in the primary
monoclonal antibody overnight at 4°C. Monoclonal antibodies
were diluted 1 in 4 in 1% NGS/0.01 M PBS/0.8% BSA/0.1% gelatin
(dilution buffer). Control sections were incubated in dilution
buffer only. Sections were then incubated in goat antimouse IgG
labeled with I nm gold particles (Auroprobe One, Amersham)
diluted 1 in 25 in dilution buffer. Following extensive washing
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Fig. 1. Normal kidney (immunoelectron microscopy). (a) ICAM-]. There is
moderately strong expression of ICAM-1 on the luminal brush border of
the proximal tubule cells (arrows). Note the absence of any staining on the
basal and lateral surfaces of the cells (X6,000). (b) VCAM-l. There is
moderately strong expression of VCAM-1 on the lateral and basal surfaces
of the proximal tubule cells (arrows). Note very little staining on the
luminal brush border (X6,000). (c) VCAM-1. VCAM-1 is strongly ex-
pressed on the lateral and basal surfaces of the proximal tubule cell on the
right (arrows) but is not expressed by the adjacent cell on the left. T,
tubule lumen; BM, tubular basement membrane (X15,000).
sections were fixed in 2% glutaraldehyde in PBS for 15 minutes the sections in Epon-Araldite. Then, 0.08 p. sections were cut
and then silver enhanced using IntenSE M kit (Amersham). straight from the surface of the block, mounted on copper grids,
Post-fixation with 1% aqueous osmium for 30 minutes was stained with lead citrate and uranyl acetate and examined in a
followed by dehydration in graded acetones and flat embedding of Philips CM12 electron microscope.
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Fig. 2. Normal kidney (immunoelectron microscopy). (a) ICAM-1. There is moderately strong ICAM-1 expression evenly distributed on the luminal
surface of the glomerular endothelium (E, arrows). 1CAM-1 is not expressed by visceral epithelium or mesangium (M). C, glomerular capillary lumen
(x 10,000). (b) VCAM-1. VCAM-1 is not expressed on any cell type within the glomerulus of the normal kidney. C, glomerular capillary lumen; M,
mesangium (X9,500). (c) VCAM-1. There is moderately strong VCAM-1 expression on the free surface of the parietal epithelium (arrows) lining
Bowman's capsule (BC). U, urinary space )<9,500.
Results arteries. By light microscopy it was not possible to determine the
precise cellular localization of [CAM-i expression within the
lmmunohzstochemtstiy glomeruli and the interstitium. In contrast, VCAM-1 expression
Wormal kidney. In the normal kidney ICAM-1 was moderately within the normal kidney was restricted to parietal epithelium and
strongly expressed in glomeruli, on parietal epithelium, within the a few proximal tubules (data not shown).
interstitium, on the luminal surface of the brush border of Allografi rejection. In the two cases which showed active inter-
proximal tubules and on the endothelium of arterioles and small stitial inflammation and foci of tubulitis, IcAM-i expression
n
i. 
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Fig. 3. Normal kidney (immunoelectron microscopy). (a) ICAM-]. This arteriole demonstrates ICAM-1 expression on the luminal surface of the
endothelium (arrows). Note moderate ICAM-1 expression on the surface of fibroblast-like interstitial cells (F). A, arteriole lumen; SM, smooth muscle
cells (x 10,000). (b) IcAM-1. A peritubular capillary with moderately strong ICAM-l expression on its endothelial surface (arrows). C, perituhular
capillary lumen; T, tubule (x9,500). (c) VCAM-1. Note absence of VCAM-1 expression on this peritubular capillary (C) compared with the strong
l(AM-1 expression in (h). T, tubule (X10,000).
Fig. 4. Renal rejection (immunoelectron microscopy). IcAM-1 expression is strong on the luminal endothelial surface (E, arrows) of this
arteriole (A) containing an intraluminal lymphocyte (L) and a monocyte (M). ICAM-i is also expressed on the surface of the monocyte (M) and
interstitial fibroblast-like cells (F) (xo,S00).
appeared to be increased although in a similar distribution to that
seen in the normal kidney. In contrast, VCAM-1 expression
appeared to be not only increased in intensity in the sites seen in
the normal kidney, but to be expressed within the interstitium and
on the endothelium of arterioles and small arteries. Both ICAM-1
and VCAM-1 expression were focally more intense at areas of
interstitial inflammation and tubular damage.
In those two cases which showed tubular atrophy and interstitial
fibrosis but an absence of active inflammation, ICAM-1 expres-
sion appeared to be of a similar strength to that seen in the normal
kidney, but VCAM-I expression was absent or extremely faint
(data not shown).
Immunoelectron microscopy
Normal kidney. ICAM-1 was moderately strongly expressed
within glomeruli in an even distribution on the luminal surface of
endothelium, but not on mesangial cells or visceral epithelium
(Fig. 1). In contrast, VCAM-I was not expressed by any cell type
within the glomerulus (Fig. I), Both ICAM-1 and VCAM-I were
moderately strongly expressed on the free surface of parietal
epithelial cells lining Bowman's capsule (Fig. I).
Within the tubulointerstitium ICAM-1 was expressed on the
luminal surface only of some proximal tubule cells (Fig. 2). In
contrast, VCAM-1 was expressed on the lateral and basal surfaces
of some cells within a few proximal tubules (Fig. 2). Within these
tubules one cell expressing strong surface VCAM-1 was seen
adjacent to another cell showing complete absence of VCAM-1
expression (Fig. 2).
Within the interstitium ICAM-1 was moderately expressed on
the surface of fibroblast-like interstitial cells and the endothelium
of peritubular capillaries (Fig. 3). In addition IcAM-1 was present
on the endothelium of arterioles and small arteries. In contrast,
VCAM-1 was seen focally on the endothelium of small arteries
but not on capillary or arteriolar endothelium or on interstitial
fibrohiast-like cells (Fig. 3).
Allograft rejection. The two biopsies which showed active rejec-
tion on light microscopy immunohistochemistry were examined by
immunoelectron microscopy.
IcAM-1 expression appeared to be increased in intensity com-
pared with normal but in a similar distribution to that seen in the
normal kidney. Within glomeruli ICAM-I expression was still re-
stricted to the endothelial surface. Within the interstitium tubular
ICAM-1 remained localized to the luminal surface of tubules.
However, tubular ICAM-1 expression was increased in intensity and
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Fig. 5. Renal allograft rejection (immunoelectron
microscopy). (a) VCAM-1. VCAM-1 expression
is strong on the surface of the plump
endothelial cells (E) in the lower right corner
of the rnicrograph (arrows) and is weaker on
the flatter cndothelial cells in the upper left
corner of the micrograph (arrowheads). The
lymphocytes (L) appear adherent at the sites of
VCAM-1 expression. C, peritubular capillary
lumen (X1O,000). (b) VCAM-1. The VCAM-1
expressing endothelium of this peritübular
capillary appears to be tethered at the sites of
adhesion of the lymphocyte (L) to the
endothelium (arrows). E, endothelial cell; C,
peritubular capillary lumen (X9,500).
involved both proximal and distal tubules. ICAM-1 was strongly and
extensively expressed on the endothelium of peritubular capillaries,
arterioles and small arteries where it was seen in association with
adherent mononuclear leukocytes, both lymphocytes and monocytes
(Fig. 4). ICAM-1 was also expressed on the entire surfaces of
interstitial fibroblast-like cells (Fig. 4).
VCAM-1, as in normal kidney, was not expressed within
glomeruli in allograft rejection. Within the interstitium VCAM-1
I
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Fig. 6. Renal alloraft rejection (immunoelectron
microscopy). (a) VCAM-1. This proximal tubule
demonstrates strong VCAM-1 expression on
the lateral and basal surfaces of the cells
(arrows) but little expression on the luminal
surface. The cells appear vacuolated and the
basement membrane is thickened. T, proximal
tubule lumen (X 10,000). (b) VCAM-1. This
damaged tubule with markedly thickened
basement membrane (BM) shows one cell in
mitosis (asterisk). The cells demonstrate strong
VCAM-1 expression on all their surfaces
(arrows). T, tubule lumen (X9,500).
was widely and strongly expressed on the endothelium of peritu- with the endothelial cells in the normal kidney (Fig. 5). The
bular capillaries and arterioles (Fig. 5). These endothelial cells endothelial expression of VCAM-1 was seen in association with
often appeared swollen with increased cytoplasm as compared adherent mononuclear leukocytes (Fig. 5). In some capillaries the
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endothelium appeared to be tethered at the sites of leukocyte
adhesion with VCAM-1 being expressed at these points (Fig. 5),
The tubular expression of VCAM-1 in the transplant kidneys was
still focal, affecting only some tubules, these usually being tubules
showing evidence of damage. However, tubular VCAM-1 was
more widely and strongly expressed in the transplant kidneys than
in the normal kidneys. As in normal kidney, tubular cell VCAM-1
expression was localized to basolateral surfaces (Fig. 6). A few
tubules showed the presence of lymphocytes between the baso-
lateral surfaces of the tubular cells. Damaged tubules occasionally
showed evidence of regeneration with mitotic activity, and these
cells also expressed VCAM-1 on all their surfaces (Fig. 6).
Discussion
Although light microscopic and functional studies have sug-
gested that leukocyte adhesion molecules ICAM-1 and VCAM-1
may be important in renal allograft rejection [2—13], this is the first
study to identify the precise ultrastructural localization of
ICAM-1 and VCAM-1 in both the normal and allografted human
kidney.
In renal transplantation T cell mediated rejection manifests
itself as: (1) intimal endothelialitis/arteritis involving adhesion of
lymphocytes to the endothelium of arterioles and small arteries,
and infiltration of lymphocytes beneath the endothelium, and (2)
tubulitis involving infiltration of lymphocytes across the basement
membrane and into the tubule [1]. Both have significant correla-
tions with destructive changes and with graft dysfunction [1]. The
mechanisms by which inflammatory cells enter the kidney and
cause damage in renal allograft rejection are not well understood.
Leukocyte adhesion molecules of the immunoglobulin superfam-
ily IcAM-1 and VcAM-1, as well as mediating specific leukocyte
to endothelial cell adhesion, are also important in leukocyte
endothelial transmigration/extravasation [18—201. We found
ICAM-1 to be moderately strongly expressed in the normal kidney
both on glomerular endothelium and endothelium throughout the
interstitium.
Although it is recognized that homing/recirculation of lympho-
cytes via high endothelial venules in lymphoid tissues involves
ICAM-1/LFA-1 interactions [21], the mechanisms regulating
transmigration of lymphocytes through other organs such as the
kidney are little understood. The expression of ICAM-i on the
endothelium of peritubular capillaries and glomerular endothe-
hum in normal human kidney may play a role in lymphocyte
recirculation in the normal healthy state. Whether endothelial
ICAM-1 is playing a critical role in ahlograft rejection is not
known, although administration of ICAM-1 antibodies decreased
T cell infiltration and prolonged graft survival in a nonhuman
primate model of renal ahlograft rejection [101. Renkonen et al
[13], who demonstrated that the site of entrance of lymphocytes
into rejecting renal allografts is the peritubular capillaries, found
that blocking with ICAM-1 antibodies did not prevent the binding
of lymphocytes to the peritubular capillaries. This suggested that
other adhesion molecules may play a more important role in
allograft rejection. In addition, we have shown that VCAM-1,
which is absent from the interstitial vessels in normal kidney, was
strongly expressed on the endothelium of peritubular capillaries
and arterioles in active rejection. Functional studies in mice have
shown that VCAM-1 antibodies prolong cardiac allograft survival
[14], but similar studies have not been performed with renal
allografts. We propose that VCAM-1 is an important adhesion
molecule in leukocyte adhesion and migration into the intersti-
tium in allograft rejection, and that it may be acting in tandem
with ICAM-1.
ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions, as well as
mediating endothelial adhesion and transmigration of leukocytes,
also play accessory roles in many immune and inflammatory
responses including antigen presentation, T cell activation and
cytotoxicity [18—20]. Hence the strong endothelial expression of
ICAM-1 and VCAM-1 which we have shown on interstitial vessels
in allografted kidneys would enhance the T cell-mediated endo-
thelial damage, a feature of the endothelialitis/endarteritis of
transplant rejection. In fact, studies by Bishop et al [22] have
demonstrated that peritubular capillaries are the major target of
the acute rejection process.
Of interest is our finding that although VCAM-1 was strongly
expressed on peritubular capillary endothelium and arteriolar
endothelium in allograft rejection, it was not expressed on gb-
merular endothelium. The phenotypic heterogeneity of glomeru-
tar and peritubular endothelial cells in human kidney has been
demonstrated by Kinjo et a! [23], and they suggested that the
different capillary beds may play different roles in the immune
system.
We have shown tubular expression of VCAM-1 is focal in
nature in that it is both present only on a small number of tubules
and only on some of the cells in those tubules. VCAM-1 expres-
sion is predominantly on the basolateral surfaces of the tubule
cells in both normal kidneys and in rejection, and we have seen
strong expression on one cell adjacent to another cell showing an
absence of VCAM-1 expression. Even though tubular VCAM-1
expression appeared to be increased in transplant rejection, the
cellular distribution was similar, that is, mainly on the lateral and
basal surfaces of the cells and was still focal in nature. The
interstitial inflammatory changes of renal transplant rejection are
usually quite focal in nature, and perhaps this may be at least
partly explained by the focal nature of VCAM-1 expression.
However, another explanation may be that the increased expres-
sion of VCAM-1 is secondary to tubular injury perhaps related to
cytokines secreted by inflammatory cells or damaged tubule cells.
The location of VCAM-1 expression on the basolateral surfaces of
the tubule cells would be well placed to interact with adhesion
molecules on the surface of inflammatory leukocytes in the
interstitium, and we postulate that VCAM- 1 may play an impor-
tant role in the pathogenesis of tubulitis in the initial adhesion of
lymphocytes to the tubule cells and subsequent damage to the
cells. In addition tubule cells express basal surface MHC Class II
and it has been postulated that the tubule cell may act as an
antigen presenting cell promoting tubular immune damage [24].
In contrast ICAM-1 expression both in normal kidneys and in
transplant rejection remained strictly confined to the luminal
surfaces of tubule cells. The role of tubular ICAM-1 is not clear,
but it may represent an alternative pathway for leukocyte entry
into the tububointerstitium [251. Another possibility is that it
represents nonspecific reabsorption of filtered ICAM-1.
In conclusion, although ICAM-1 expression appears to be
up-regulated in renal albograft rejection in a similar pattern of
distribution to that seen in the normal kidney, we postulate that it
is VCAM-1 which appears on the peritubular capillary endothe-
hum and is strongly focally expressed on the basolateral surfaces
of tubules, which is perhaps more strategically placed to be the
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most relevant adhesion molecule in allograft rejection. Adminis-
tration of blocking antibodies to VCAM-I could potentially block
the adhesion of mononuclear inflammatory leukocytes to the
endothelium of peritubular capillaries and arterioles and the
subsequent damage to these cells by cytotoxic T cells, transmigra-
tion of mononuclear leukocytes out from the capillaries into the
interstitium, and mononuclear leukocyte interaction with and
subsequent damage to the tubule epithelial cells.
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